<DOC>
	<DOCNO>NCT01509339</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics safety inhale vancomycin patient cystic fibrosis .</brief_summary>
	<brief_title>Pharmacokinetics Vancomycin Inhalation Cystic Fibrosis</brief_title>
	<detailed_description>The prevalence methicillin resistant Staphylococcus aureus ( MRSA ) respiratory infection patient cystic fibrosis increase dramatically last decade . Epidemiologic evidence suggest persistent infection MRSA may result increased rate decline FEV1 shorten survival . Treatment MRSA top priority . Inhaled antibiotic offer advantage high concentration antibiotic site infection ( airway ) minimize systemic side effect . Vancomycin glycopeptide antibiotic activity MRSA . Anecdotal retrospective peer-reviewed study demonstrate inhaled vancomycin safe potentially effective patient cystic fibrosis MRSA airway infection . Data evaluate pharmacokinetics vancomycin sputum need pursue treatment trial .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Male female ≥ 18 year age . Confirmed diagnosis CF base follow criterion : positive sweat chloride &gt; 60 mEq/liter ( pilocarpine iontophoresis ) and/or genotype two identifiable mutation consistent CF abnormal NPD , one clinical feature consistent CF phenotype . Chronic sputum producer able spontaneously produce sputum FEV1 &gt; 40 % predict normal age , gender , height Previous use inhale antibiotic within last year Ability provide write informed consent Ability adhere protocol Use inhale intravenous vancomycin within two week study visit Known history intolerance inhale vancomycin inhale albuterol . Known history hypersensitivity vancomycin glycopeptide antibiotic History sputum culture Burkholderia cepacia complex last two year . Pregnancy Woman lactate willing stop nursing day study visit subsequent 48 hour . Current use oral corticosteroid dos exceed equivalent 10mg prednisone day 20mg prednisone every day . Patients willing hold inhale antibiotic ( example TOBI , Cayston , Colistin ) least 2 day prior study visit . Patients willing hold loop diuretic ( i.e . furosemide , torsemide , ethacrynic acid ) morning study visit . History ABPA reactive airway disease require treatment within last year . Creatinine great 2.0 mg/dL within last year . Oxygen saturation ≤ 92 % room air . History patient report hearing loss Any serious active medical psychiatric illness , opinion investigator , would interfere patient treatment , assessment , adherence protocol . History list solid organ hematological transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Vancomycin</keyword>
	<keyword>Inhalation</keyword>
	<keyword>Nebulization</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>